SHAILY Shaily Engineering Plastics Q1 FY27 results (Apr–Jun 2026) and concall
Shaily Engineering Plastics Limited reported a strong Q1 FY27 with consolidated revenue growing 14% and EBITDA up 18%, driven primarily by an 85% surge in its Healthcare segment. The company successfully secured new orders for injector pens and expanded its global business development team. While the Consumer segment faced headwinds from softer demand, management expects gross margins to normalize and is confident in its full-year guidance, with significant progress on new product development and capacity expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 22.2%, net profit up 44.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 180 | 186 | 203 | 225 | 236 +31% | 236 +27% | 224 +10% | 275 +22% |
| EBITDA | 31 | 38 | 48 | 61 | 68 +119% | 64 +68% | 63 +31% | 86 +41% |
| Net profit | 13 | 18 | 30 | 36 | 41 +215% | 36 +100% | 49 +63% | 52 +44% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





